Max is co-founder and CEO of Implandata Ophthalmic Products GmbH. He has extensive experience in the commercial development of technologically advanced products, in building operational capabilities for aggressively growing companies and in creating businesses, attracting potential acquirers in the global market. As a serial entrepreneur, he was founder and CEO of a German medical device start-up, developing a new to the world portable medical device for rapid detection of intracranial bleeding, which was acquired by a US-based company in 2007. Mr. Ostermeier was also co-founder and CEO of a medical technology company with innovative neurosurgical products whose technology was acquired 4 years after foundation by a leading US medical device company. Prior to that, he was instrumental in creating for a globally leading fine chemistry company their biotech entity, where he served as General Manager and Vice-President until this company was divested.